HCMHUTCHMED (China) Limited

$3B

Q4 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$116M+3.0% YoY

Gross Profit

$41M35.6% margin

Operating Income

-$40M-34.8% margin

Net Income

-$44M-37.6% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

+97.3%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$13M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$532M

Total Liabilities

$120M

Stockholders' Equity

$389M

Cash & Equivalents

$86M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$116M	$113M	+3.0%
Gross Profit	$41M	$28M	+49.2%
Operating Income	-$40M	-$37M	-10.0%
Net Income	-$44M	-$28M	-56.3%

HCM Q4 2018 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena